WCY-8-67
WCY-8-67 is an orally active and selective USP5 inhibitor, with an IC50 value of 1.33 μM. WCY-8-67 induces apoptosis and suppresses JAK/STAT3 and PI3K/AKT signaling pathways in vitro. WCY-8-67 inhibits proliferation of AE-positive AML cells, induces G1 phase arrest and differentiation of AML cells. WCY-8-67 demonstrates potent anti-leukemic efficacy in mice. WCY-8-67 can be used for the study of acute myeloid leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3052618-54-6
- Formule: C25H32FN7
- Masse moléculaire:449.57
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
USP5 1.33 μM (IC50) |
In Vitro
WCY-8-67 (0.5-2 μM, 24 h) dose-dependently reduces AML1-ETO (AE) protein abundance in Kasumi-1 and Skno-1 cells[1].
WCY-8-67 (0.5-2 μM, 24 h) inhibits proliferation of AE-positive AML cells (Kasumi-1: IC50 = 1.75 μM; Skno-1: IC50 = 0.99 μM; U937-AE: IC50 = 1.20 μM), but shows negligible effect on AE-negative AML cells (MV-4-11, MOLM-13, HL-60)[1].
WCY-8-67 (0.5-7.5 μM, 24-48 h) induces apoptosis and G1 phase cell cycle arrest in Kasumi-1 and Skno-1 cells[1].
WCY-8-67 (0.5-2 μM, 7 days) reduces colony formation of Kasumi-1 and Skno-1 cells in agarose colony assays, decreasing the number of malignant clones[1].
WCY-8-67 (0.5-2 μM, 24 h) decreases CD34+CD38- leukemia stem cell (LSC) population and increases CD11b+ differentiated cell population in Kasumi-1 and Skno-1 cells[1].
WCY-8-67 (0-2.5 μM, 24 h) suppresses JAK/STAT3 and PI3K/AKT signaling pathways in Kasumi-1 and Skno-1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Kasumi-1 and Skno-1 cells
-
Concentration:0, 1.25, 5, 7.5 μM
-
Incubation Time:48 h
-
Result:Downregulated MDM2 and upregulated p53.
Promoted cleavage of PARP1 and activation of caspase-3.
Reduced anti-apoptotic proteins Bcl-2 and Mcl-1.
In Vivo
WCY-8-67 (40 mg/kg, p.o., once daily, 42 days) reduces tumor burden and extends survival in Kasumi-1-luciferase-GFP orthotopic xenograft model[1].
WCY-8-67 (20 mg/kg, i.p., once daily, 14 days) prolongs survival and reduces spleen weight in t(8;21) AML xenograft (PDX) model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Skno-1 cells (1 × 107) were subcutaneously implanted into the flanks of 6-week-old female NU/NU mice[1]
-
Dosage:20, 40 mg/kg
-
Administration:p.o., once daily, 12 days
-
Result:Reduced tumor weight and volume.
Showed no significant changes in body weight.
-
Animal Model:Kasumi-1 cells expressing luciferase-GFP (2 × 106) were intravenously injected into the tail veins of the 6-week-old NOG mice[1]
-
Dosage:40 mg/kg
-
Administration:p.o., once daily, 42 days
-
Result:Decreasedspleen weight and hCD45+ leukemic cell percentage in bone marrow, spleen, and peripheral blood.
Reduced tumor burden and extends survival.
-
Animal Model:Primary t(8;21) AML cells were intravenously injected into the tail veins of the 6-week-old NOG mice[1]
-
Dosage:20 mg/kg
-
Administration:i.p., once daily, 14 days
-
Result:Decreased hCD45+ cell infiltration in bone marrow, spleen, and peripheral blood.
Prolonged survival and reduces spleen weight.
Chemical Information
-
CAS No. 3052618-54-6
-
Masse moléculaire 449.57
-
Formule C25H32FN7
-
SMILES
CN(C)CCN(C1=C2C(CN(C3=C4C=CC=CC4=C(F)C=C3)C2)=NC(N5CCNCC5)=N1)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)